The Practice of Anita Sadaty, M.D.
Great Neck Obstetrics and Gynecology is dedicated to continually improving and providing state of the art comprehensive medical care for women's health. Each physician in the practice enhances the high level of care provided to their patient population by sharing their individual brand of medical and surgical expertise.
Obstetrics:
The Long Island New York office offers a comprehensive team approach to our obstetrical patients - our obstetricians, high-risk specialist, trained labor and delivery nurses and on-site radiologist work together to assure our obstetrical patients receive round the clock, quality care.Our practice offers high-risk obstetrical care with a full time perinatologist (maternal fetal medicine specialist). We offer specialized care for multi-fetal pregnancy, patients with a history of recurrent pregnancy loss, preterm delivery history and poor obstetrical history.
We perform all obstetrical ultrasound and prenatal care services in our office as well as all ultrasound-related procedures including:
- Ultrascreen
- Level 2 Comprehensive Ultrasound
- Multifetal Growth Assessment
- Amniocentesis
- Non-stress Testing
- Biophysical Profiles
- Color Doppler studies to assess placental function and fetal well-being
- 3 Dimensional ultrasound to assess anatomy
- Pre-conception Genetic Counseling and on-site testing for Cystic Fibrosis, Gaucher's Disease, Tay-Sach's, Canavan's, Familial Dysautonomia, Sickle Cell Disease, Thalassemias, Fanconi's anemia, etc.
Well Woman Care:
We are proud to offer our patients health care screening following the American Cancer Society Guidelines for well-woman health care surveillance:
- Annual Breast Exam: For early detection of breast disease
- Pap testing, colposcopy, LLETZ and cryosurgery: Cervical cancer screening, diagnosis and treatment for precancerous lesions of the cervix.
- Bone Densitometry: for early detection of osteoporosis
- Annual Well Woman Screening: for cholesterol, thyroid dysfunction, diabetes.
- Pelvic Ultrasound and CA-125: Screening for ovarian cancer in high risk individuals
- HPV Vaccinations: for the prevention of cervical cancer, cervical dysplasia and condyloma
- The HALO Breast Pap Test can detect cellular abnormalities years before a larger, potentially cancerous lesion might develop:
The HALO Breast Pap Test
The HALO Breast Pap Test has been FDA approved for the collection of nipple aspirate fluid (NAF) to identify abnormal cells which may put women at increased risk for developing breast cancer. By incorporating the HALO system into routine practice physicians and patients will be able to monitor cellular changes within breast ducts earlier, before they develop into larger, potentially cancerous changes that may not be detected by conventional breast cancer screening modalities like mammography or manual breast examination until many years later.
Minimally Invasive Surgical Procedures:
Our practice is proud to offer the most advanced laparascopic procedures developed to date, offering a wide range of minimally invasive services for patients and a wide array of treatment options for a variety of gynecological conditions. Laparoscopic hysterectomy, laparoscopic myomectomy, operative hysteroscopic fibroid treatment, alternative tubal ligation procedures (known as Essure), and Novasure, Thermachoice and rollerball endometrial ablation procedures for severe bleeding disorders are a few of the most commonly used and minimally invasive procedures offered by our office.
What is an Essure device? The Essure device offers women and their partners a gentler option in permanent birth control. Unlike tubal ligation and vasectomy, there are no punctures, and no cutting, clipping or cauterizing of tubes. Also, it is typically performed without general anesthesia and takes as little as 45 minutes.
What Is a Laparoscopic Hysterectomy? Laparoscopic hysterectomy is a relatively new surgical procedure that allows the uterus to be detached from inside the body by laparoscopic instruments while the doctor is viewing the uterus, tubes, and ovaries through a camera attached to a telescope. After the uterus is detached, it is removed through a small incision at the top of the vagina. One advantage of laparoscopic hysterectomy is that the incisions are smaller (1/2 inch) and much less uncomfortable than that of abdominal hysterectomy. Also, the hospital stay of 1 day and the ability to resume normal activity in about 2 weeks are substantially shorter than for abdominal hysterectomy and slightly shorter than for vaginal hysterectomy.
What is operative hysteroscopy? Hysteroscopy is a procedure that allows a visual examination of the interior of the uterus and is performed by inserting a long, slender instrument directly into the uterus via the cervix. The diagnostic procedure usually takes a few minutes. An operative hysteroscopy allows the gynecologist to remove abnormal tissue such as polyps, fibroids that protrude into the uterine cavity or scar tissue. It is performed under general anesthesia and generally takes between 30 to 60 minutes to perform depending on the extent of the surgery required. The patient is sent home after 1 to 2 hours in recovery and may resume full activites by the following morning.
Urodynamics and Evaluation of Female Urinary Stress Incontinence:
Urinary incontinence is the accidental release of urine. This leakage often occurs when you cough, laugh, sneeze, or have sudden urges to go to the bathroom and can't get there in time. Incontinence is not a disease but a symptom of a problem and is very common, especially among women. Typically, urinary incontinence does not cause major health problems, but it can be embarrassing and can affect a woman's self-esteem and confidence.
Our office is fully equipped to perform complex Urodynamic Testing, using the The Lumax Pro Cystometry System I - a state-of-the-art, incontinence diagnostic system that more accurately diagnoses the various cause of female urinary incontinence. Urodynamic testing provides a more advanced way to check bladder function and to determine if incontinence symptoms are due to overactive bladder, pelvic floor relaxation, disorders of the urethra, or a combination of many factors.
Radiologic Services:
Our practice is proud to have Dr. Beth Gross, a radiologist who specializes in ultrasound evaluation for obstetrics and gynecology. She has written several chapters for a variety of prominent ultrasound textbooks, and is an associate professor at North Shore University hospital and New York University Departments of radiology.
Obstetrical ultrasounds performed in pregnancies include early first trimester screening (known as the ultrascreen), ultrasound-guided amniocentesis, comprehensive level II anatomy screens, cervical length screening for preterm labor prevention, biophysical profiles and fetal growth evaluations in the third trimester, and multifetal pregnancy evaluation. We also offer state of the art 3-D ultrasound in our facility, available to our obstetrical and gynecologic practice.
Gynecologic ultrasound includes ovarian cancer screening assessment, pelvic and transvaginal ultrasound and sonohysterography for evaluation of uterine abnormalities.
We have on-site bone densitometry for early detection of osteopenia and osteoporosis and counseling available for patients regarding this important women's health care issue.
The Halo Breast Pap Test:
The HALO System is a simple, reliable method for NAF collection. NAF analysis is an objective assessment of a patient's breast health and can detect early warning signs of ductal cellular changes.
Regular assessment and tracking of cellular changes in the milk ducts, where most breast cancer begins, enables clinicians and patients to take control of breast health. Consider the following facts:
- 1 in 8 women will develop breast cancer in their lifetime
- 7 of 8 breast cancer patients have no direct family history of breast cancer
- 70% of women who develop breast cancer have no identifiable risk factors other than age
- Younger women face unique issues:
» Breast cancer is the leading cause of death for American women ages 35 to 50.
» Younger women with breast cancer have worse outcomes and more advanced disease than older women.
» Breast cancer diagnosis within two years of childbirth has nearly 50% mortality.
» Excluding skin cancer, the breast is the leading site of cancer among women.
Breast cancer also ranks a women's number one health concern today, as warranted by the following statistics: In the United States, the average woman has a 12.5 percent lifetime risk of developing invasive breast cancer.
Until recently, the standard care for screening women to assess their breast health and risk of developing breast cancer was review of family history, physical breast exam, plus regular mammography
for women over 40 or 50. However, clinical experience has shown that none of these methods is effective in identifying cancers at the cellular level. By the time the cancer is detected by either physical
examination or mammography, the woman may have had the disease for six to ten years, with significant risk of serious consequences - including death. In addition, it should be noted that more than 70% of
breast lumps are initially found through self-examination. Learn more about the HALO Breast Pap Test.
Comprehensive Genetics Counseling:
Pre-natal Genetics Counseling
Dr. Sadaty's office offers Pre-natal Genetics Counseling and formal genetic evaluation for couples with poor pregnancy history, recurrent miscarriages and couples who may be at risk for genetic diseases based on ethnicity and country of origin.
After an evaluation, recommendations for tests may include carrier screening for Cystic Fibrosis, Gaucher's Disease, Tay-Sach's, Canavan's, Familial Dysautonomia, Sickle Cell Disease, Thalassemias, Fanconi's anemia, Niemann-Pick (type A) disease, Bloom syndrome, HTLVIII, Mucolipidosis and Fragile X testing.
Patient's of Ashkenazi Jewish descent may be at risk for carrying genes that could lead to uncommon, yet severe, incurable neurodegenerative and other diseases in their newborns. There is currently genetic screening available for Tay-Sachs disease, Canavan disease, Familial Dysautonomia, Niemann-Pick disease, Fanconi's anemia, Bloom syndrome, Gaucher's disease, mucolipidosis type IV,and glycogen storage disease type 1.
Cystic fibrosis (a progressive, chronic lung disorder that leads to death in young adulthood) is found mostly in Caucasian populations, and Hemoglobin electrophoresis (to screen for blood disorders) is often recommended for individuals of Asian or Mediterranean descent.
Fragile X Syndrome is the most common cause of inherited mental retardation. Carrier screening for this disorder is available. The American College of Medical Genetics and the American College of Obstetrics and Gynecology established the most recent guidelines for Fragile X syndrome carrier which state that anyone with a family history of undiagnosed mental retardation should be considered for Fragile X syndrome carrier testing.
BRCA-1/2 Genetic Counselling
BRACAnalysis is a genetic test that requires only a blood sample to determine whether a patient has a BRCA1 or BRCA2 gene mutation, indicating a predisposition to hereditary breast and ovarian cancer (HBOC). Once genetic risk is identified, there are specific management strategies that can be employed for early detection, risk reduction and possible prevention of these cancers.
We offer a full evaluation for carrier screening that is appropriate for you with a detailed explanation of how carrier screening can affect your unborn child.